Intestinal microbiota in liver diseases: current state of the problem

Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 3

Abstract

The article presents analysis of the recent literature data, the results of experimental and clinical studies on role of participation the intestinal microbiota in the pathogenesis of various liver diseases: viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, primary sclerosing cholangitis, liver cirrhosis and hepatocellular carcinoma. Particular attention is paid to increasing intestinal permeability, which creates conditions for bacterial translocation, activation of the systemic inflammatory response, increased hyperdynamic blood flow and deterioration of the functional state of the liver. As a striking example of the effect of intestinal microbiota on the state of the liver, data on small intestinal bacterial overgrowth syndrome (SIBR) are presented. There was a high incidence of SIBR in chronic liver diseases, a relationship between increased intestinal permeability and severity of impaired liver function, development and severity of hepatic encephalopathy, and the likelihood of spontaneous bacterial peritonitis. Role of intestinal microbiota in the development of bacterial complications in liver cirrhosis, especially spontaneous bacterial peritonitis, is discussed. It is shown that intestinal dysbiosis is involved in dysregulation of the cell death/regeneration balance that underlies carcinogenesis. It is concluded that it is reasonable to include drugs correcting the composition of intestinal microbiota in therapy of a number of liver diseases. The advantages of rifaximin administration have been outlined in the improvement of liver functional state at non-alcoholic steatohepatitis, hepatic encephalopathy by means of correcting the composition of the intestinal microbiome.

Authors and Affiliations

N. B. Gubergrits, N. V. Byelyayeva, E. V. Berezhna, A. Ye. Klochkov, P. G. Fomenko, A. V. Tsys

Keywords

Related Articles

The peculiarities of some gastroenterological diseases in elderly patients

The data presented in the paper were based on the recent investigations and currentrecommendations. The pathological changes in the gastroenterological profile are proved to be most prevalent in subjects aged 65 years an...

Functional dyspepsia and immune dysfunction: modern concepts of pathogenetic mechanisms of their development

The review presents the main modern opinions on the immunological factors of functional dyspepsia development and data on its micromorphological basis. The immune dysfunction is considered as an important factor in the p...

Age-related and hormonal and metabolic peculiarities of patients with non-alcoholic fatty liver disease in combination with subclinical hypothyroidism

Objective — to identify age-related and hormonal and metabolic features in patients with non-alcoholic fatty liver disease (NAFLD) in combination with subclinical hypothyroidism (SH). Materials and methods. The study in...

The gastroenterological manifestations of methotrexate effects in pediatric patients with the juvenile idiopathic arthritis

The paper elucidates the most prevalent gastroenterological manifestations of methotrexate effects in the treatment of juvenile idiopathic arthritis (JIA) in pediatric patients. Some considerable changes took place in th...

Irritable bowel syndrome at young age: Salofalk treatment efficacy

Objective — to analyze the effect of granules of mesalazine on the course of IBS in adolescents and young patients. Materials and methods. We observed 58 children in late adolescence from 15 to 18 years old and 120 youn...

Download PDF file
  • EP ID EP616019
  • DOI 10.30978/MG-2019-3-79
  • Views 135
  • Downloads 0

How To Cite

N. B. Gubergrits, N. V. Byelyayeva, E. V. Berezhna, A. Ye. Klochkov, P. G. Fomenko, A. V. Tsys (2019). Intestinal microbiota in liver diseases: current state of the problem. Сучасна гастроентерологія, 0(3), 79-90. https://europub.co.uk/articles/-A-616019